141 related articles for article (PubMed ID: 36253584)
1. Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma.
Chung YS; Jeon Y; Yoo JE; Chung T; Ryu HJ; Kim H; Rhee H; Park YN
Hepatol Int; 2023 Feb; 17(1):77-85. PubMed ID: 36253584
[TBL] [Abstract][Full Text] [Related]
2. Nestin may be a candidate marker for differential diagnosis between small duct type and large duct type intrahepatic cholangiocarcinomas.
Sasaki M; Sato Y; Nakanuma Y
Pathol Res Pract; 2024 Jan; 253():155061. PubMed ID: 38154357
[TBL] [Abstract][Full Text] [Related]
3. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
Ferrone CR; Ting DT; Shahid M; Konstantinidis IT; Sabbatino F; Goyal L; Rice-Stitt T; Mubeen A; Arora K; Bardeesey N; Miura J; Gamblin TC; Zhu AX; Borger D; Lillemoe KD; Rivera MN; Deshpande V
Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926
[TBL] [Abstract][Full Text] [Related]
4. A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization.
Avadhani V; Cohen C; Siddiqui MT; Krasinskas A
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):175-179. PubMed ID: 33181516
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
[TBL] [Abstract][Full Text] [Related]
6. Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma.
Brackett DG; Neyaz A; Arora K; Masia R; Mattia A; Zukerberg L; Misdraji J; Goyal L; Zhu AX; Ferrone CR; Yilmaz OH; Deshpande V
J Clin Pathol; 2020 Jan; 73(1):23-29. PubMed ID: 31422372
[TBL] [Abstract][Full Text] [Related]
7. Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites.
Nasir A; Lehrke HD; Mounajjed T; Said S; Zhang L; Yasir S; Shah SS; Chandan VS; Smyrk TC; Moreira RK; Boland Froemming JM; Herrera Hernandez LP; Wu TT; Graham RP
Am J Clin Pathol; 2019 Jul; 152(2):190-199. PubMed ID: 31107526
[TBL] [Abstract][Full Text] [Related]
8. Filamin A is involved in human intrahepatic cholangiocarcinoma aggressiveness and progression.
Vitali E; Franceschini B; Milana F; Soldani C; Polidoro MA; Carriero R; Kunderfranco P; Trivellin G; Costa G; Milardi G; Di Tommaso L; Torzilli G; Lleo A; Lania AG; Donadon M
Liver Int; 2024 Feb; 44(2):518-531. PubMed ID: 38010911
[TBL] [Abstract][Full Text] [Related]
9. Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma.
Moy AP; Arora K; Deshpande V
Histopathology; 2016 Sep; 69(3):423-30. PubMed ID: 26841202
[TBL] [Abstract][Full Text] [Related]
10. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
[TBL] [Abstract][Full Text] [Related]
11. C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
Yeh YC; Lei HJ; Chen MH; Ho HL; Chiu LY; Li CP; Wang YC
Am J Surg Pathol; 2017 Dec; 41(12):1630-1641. PubMed ID: 28945626
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance.
Komuta M
Clin Mol Hepatol; 2022 Jul; 28(3):396-407. PubMed ID: 35032970
[TBL] [Abstract][Full Text] [Related]
13. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".
Braxton DR; Saxe D; Damjanov N; Stashek K; Shroff S; Morrissette JD; Tondon R; Furth EE
Hum Pathol; 2017 Apr; 62():232-241. PubMed ID: 28232156
[TBL] [Abstract][Full Text] [Related]
15. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
Liao P; Cao L; Chen H; Pang SZ
Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
[TBL] [Abstract][Full Text] [Related]
16. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
[TBL] [Abstract][Full Text] [Related]
17. The significance of galectin-3 immunohistochemistry, clinical characteristics and liver imaging in differentiating intrahepatic cholangiocarcinoma from adenocarcinoma liver metastasis.
Dechaphunkul A; Kanngurn S; Dechsukhum C; Tanutit P; Khow-Ean U; Sunpaweravong P
J Med Assoc Thai; 2010 May; 93(5):523-8. PubMed ID: 20524437
[TBL] [Abstract][Full Text] [Related]
18. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
19. Keratin 19-expressing hepatocellular carcinoma and small-duct type intrahepatic cholangiocarcinoma show a similar postoperative clinical course but have distinct genetic features.
Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
Histopathology; 2019 Sep; 75(3):385-393. PubMed ID: 31017316
[TBL] [Abstract][Full Text] [Related]
20. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]